Freezing nerves may beat standard pain shots after lung surgery
NCT ID NCT07099469
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This small pilot study with 6 people compares two ways to manage pain after minimally invasive lung cancer surgery. One method uses a standard numbing injection (ropivacaine), while the other uses cryotherapy to freeze the nerves for longer-lasting pain relief (1-3 months). The goal is to see if cryotherapy reduces the need for pain medication and improves recovery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Antwerp
Edegem, Antwerp, 2560, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple CT scan catch lung cancer earlier in kuwait?
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Your Tumor's DNA might predict immunotherapy success
- Can a new PET tracer light up hidden cancers?
- Fellow veterans may hold the key to earlier lung cancer detection